Combine Focused Shockwave Therapy with PRP for Tendonitis

To combine focused shockwave therapy with PRP for tendonitis, clinicians typically deliver 2 to 4 sessions of focused extracorporeal shockwave therapy (fESWT) to target tissue prior to administering an autologous PRP injection. Pretreating the chronic tendinopathic lesion with acoustic energy stimulates microvascular recruitment and cellular permeability, optimizing the recipient tissue environment for concentrated biological growth factors. Reviewing protocol timing, energy parameters, and practice workflows for focused shockwave devices and autologous biologics helps clinical teams standardize dual-modal tendinopathy care.

Biological Mechanism of Dual-Modal Therapy in Tendinopathy

Chronic tendinopathy is characterized by failed healing responses, disarrayed collagen networks, hyperneurovascularization without functional capillary perfusion, and localized extracellular matrix (ECM) degradation. Treating these lesions requires both physical disruption of pathological tissue and biochemical orchestration of cellular repair.

Mechanotransduction via Focused Shockwave

Focused shockwave therapy transmits high-energy acoustic pulses directly into hypovascular focal lesions. Unlike radial pressure waves, which dissipate energy near the skin surface, focused shockwave devices allow clinicians to precisely select focal depths, delivering targeted energy density to deep-seated tendinopathies such as the proximal plantar fascia, patellar tendon, or supraspinatus insertion.

The acoustic impulses generate micro-cavitation bubbles and mechanical shear stress, triggering a mechanotransduction cascade. At the cellular level, this physical stress stimulates expressional changes in tenocytes, inducing:

• Upregulation of vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (eNOS), driving microvascular neovascularization.
• Recruitment of circulating mesenchymal progenitor cells to the zone of degeneration.
• Breakdown of calcified deposits and disrupted extracellular matrix components.
• Transient hyperstimulation analgesia by depleting Substance P in local nociceptors.

Biochemical Signaling via Platelet-Rich Plasma

While fESWT establishes a receptive structural and vascular framework, autologous biologics such as platelet-rich plasma provide the biochemical substrate required for sustained matrix synthesis. Concentrated platelets release a dense array of alpha-granule proteins, including transforming growth factor-beta (TGF-β), platelet-derived growth factor (PDGF), and fibroblast growth factor (FGF).

When injected into an fESWT-primed tendon niche, these growth factors stimulate tenocyte proliferation, increase type I and type III collagen synthesis, and recruit local stromal cells. Combining mechanical and biological therapies creates a complementary healing environment where acoustic energy alters the structural landscape and biological signaling sustains cellular repair.

Staging and Sequencing: Clinical Protocol Options

Integrating acoustic wave energy with orthobiologic injections requires careful consideration of treatment timing, soft tissue healing dynamics, and local inflammatory responses. Clinics typically utilize one of three primary staging strategies based on chronicity and patient presentation:

Protocol A: Pre-Injection Priming (Sequential Approach)

In this model, the patient receives 1 to 3 fESWT sessions spaced 7 to 10 days apart prior to the PRP injection.

• Rationale: Pre-treating the degenerate region with fESWT enhances local microvascular circulation, breaks down unorganized fibrous tissue, and recruits native progenitor cells before introducing the platelet concentrate.
• Execution: The final pre-injection fESWT session is delivered either 48 hours before or on the same day as the ultrasound-guided PRP injection. After injection, fESWT is temporarily paused to avoid disrupting initial fibrin clot formation.

Protocol B: Concurrent Combined Delivery

For patients with tight treatment windows or high-grade tendinopathy, clinicians may deliver fESWT immediately prior to the PRP injection in a single clinical visit.

• Rationale: Performing fESWT immediately before injection hyper-sensitizes the target region, localized hyperemic response, and optimizes the structural environment to retain the injected biologic.
• Execution: High-energy focused shockwave is targeted under ultrasound navigation to the focal hypo-echoic lesion. Immediately following the shockwave procedure, the site is prepared in a sterile fashion, and PRP is injected under continuous ultrasound guidance.

Protocol C: Post-Injection Acoustic Re-Activation

This approach delivers a single PRP injection followed by low-to-medium intensity fESWT 3 to 4 weeks later.

• Rationale: Initiating mild acoustic shockwave stimulation weeks after injection aims to re-trigger mechanical signaling during the tissue remodeling phase, encouraging tenocytes to align newly synthesized collagen fibers along lines of mechanical stress.
• Execution: Low energy flux density (EFD) settings are selected to provide gentle mechanical stimulation without disrupting newly formed extracellular collagen matrices.

Patient Selection and Clinical Indications Checklist

Not every tendon presentation requires dual-modal intervention. Physicians evaluating patient candidacy should review structural, temporal, and anatomical parameters to ensure appropriate clinical utility.

• Chronicity: Symptoms persisting beyond 6 months that have failed conservative physical therapy, eccentric loading, and monotherapeutic interventions.
• Structural Tendon Status: Ultrasound or MRI confirmation of chronic tendinopathy, focal hypoechoic areas, or partial-thickness micro-tears without complete structural disruption.
• Anatomical Targets:
• Lateral and Medial Epicondylalgia
• Mid-portion and Insertional Achilles Tendinopathy
• Patellar Tendinopathy (Jumper's Knee)
• Proximal Plantar Fasciitis
• Rotator Cuff Tendinopathy (without full-thickness tear)
• Contraindications Check:
• Active systemic infection or localized skin infection at the site.
• Bleeding disorders or current use of anticoagulant therapy.
• Recent corticosteroid injections within the prior 6 to 8 weeks.
• Malignancy in the target tissue region.

Practice Operations and Economic Considerations

For medical practice managers and clinical directors, introducing a combined fESWT and PRP protocol requires optimizing workflow, capital equipment allocation, and service-line logistics within an outpatient setting.

Consumable and Equipment Management

Deploying advanced devices like focused shockwave systems involves evaluating energy source longevity (e.g., electromagnetic vs. electrohydraulic applicators) and per-shock cost parameters. Unlike radial devices that require frequent handpiece overhauls, focused systems require tracking total shock count per protocol to budget for ongoing maintenance.

Simultaneously, PRP supply chain planning relies on maintaining adequate inventory of dual-spin or single-spin centrifugation kits, blood draw supplies, and ultrasound sterile covers. Matching kit volume capacities (e.g., 30 mL vs 60 mL whole blood draws) to specific tendon sizes ensures consistent platelet yield without unnecessary consumable waste.

Workflow and Staffing Efficiency

A streamlined multi-modal protocol minimizes patient total chair time while preserving clinical focus. Medical assistants handles pre-procedure preparation, patient positioning, blood draw, and centrifuge processing, allowing the treating physician to focus on acoustic wave targeting and ultrasound-guided biological delivery.

Combining these services within structured sports medicine or orthopedic appointment blocks maximizes suite utilization and optimizes clinical productivity.

What This Means for Your Practice

To successfully implement a combined focused shockwave and PRP protocol for chronic tendinopathies, consider the following immediate operational actions:

1. Standardize Clinical Protocols: Establish written guidelines detailing patient selection criteria, energy setting ranges, centrifuge spin parameters, and spacing between fESWT and injection dates.
2. Align Supply Chains: Ensure your procurement model balances reliable biologic extraction kits with low per-treatment device operating costs.
3. Cross-Train Clinical Staff: Train clinical support staff on biologic blood processing, device setup, patient positioning, and standardized post-procedure rehabilitation instructions.
4. Audit Patient Outcomes: Track clinical metrics using validated patient-reported outcome measures (e.g., VISA-A, VISA-P, or DASH scores) to continuously evaluate procedural efficacy and refine treatment staging.

Advancing Your Regenerative Service Line

Integrating focused shockwave technology with high-yield orthobiologics provides clinical practices with a structured, non-surgical approach for addressing chronic, recalcitrant tendon disorders. Dallas Regenerative Solutions supplies healthcare providers with medical-grade shockwave devices, specialized biologic processing supplies, and comprehensive practice integration support.

To learn more about optimizing your practice's clinical protocols and technology selection, contact us to speak with an experienced medical device and biologics specialist.